Medicamen Biotech plans partial shutdown of plant at Bhiwadi

20 Jan 2021 Evaluate

Medicamen Biotech (MBL) has planned a partial shutdown of its plant at Bhiwadi (Rajasthan) for 4 to 6 weeks. During this upgradation the production/activities shall remain partially suspended. The upgradation would not only enable MBL to prepare for regulated market but also provide next level of growth in terms of good volume business with better margins.

Medicamen Biotech is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets.

Medicamen Biotech Share Price

381.90 -8.35 (-2.14%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×